Sponsor Pipeline

Biocity Biopharmaceutics Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
4
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06819826 A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria IgA Nephropathy (IgAN) Recruiting
Phase 2
NCT05687890 A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney… Diabetic Kidney Disease Active, Not Recruiting
Phase 1/2
NCT07469774 BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or… Locally Advanced or Metastatic Solid Tumors Recruiting
Phase 1
NCT06548672 A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in… Advanced Cancer Recruiting
NCT07368478 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary… Advanced Solid Malignancies Recruiting
Disease Areas
Get alerts when Biocity Biopharmaceutics Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free